A detailed history of Ensign Peak Advisors, Inc transactions in Xencor Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 36,527 shares of XNCR stock, worth $924,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,527
Previous 36,527 -0.0%
Holding current value
$924,133
Previous $691,000 6.22%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$18.65 - $26.52 $34,371 - $48,876
-1,843 Reduced 4.8%
36,527 $808,000
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $1.91 Million - $2.71 Million
-73,468 Reduced 65.69%
38,370 $1.07 Million
Q4 2022

Feb 13, 2023

BUY
$24.79 - $30.86 $2.15 Million - $2.68 Million
86,768 Added 346.1%
111,838 $2.91 Million
Q3 2022

Nov 14, 2022

SELL
$24.62 - $32.44 $1.65 Million - $2.17 Million
-66,905 Reduced 72.74%
25,070 $651,000
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $363,018 - $533,493
18,390 Added 24.99%
91,975 $2.52 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $1.28 Million - $1.99 Million
47,795 Added 185.32%
73,585 $1.96 Million
Q4 2021

Feb 11, 2022

SELL
$33.67 - $43.44 $613,130 - $791,042
-18,210 Reduced 41.39%
25,790 $1.04 Million
Q1 2020

May 11, 2020

BUY
$20.69 - $37.79 $91,036 - $166,276
4,400 Added 11.11%
44,000 $1.32 Million
Q4 2019

Feb 14, 2020

BUY
$32.75 - $41.43 $1.3 Million - $1.64 Million
39,600 New
39,600 $1.36 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.51B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.